H. Reichl

Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment.

L. Biesert, J. Römisch, T. Schmidt, 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins?

A. Balen, C. Jansen, H. Reichl, 2002, Human reproduction.

Infectivity in the blood of mice with a BSE-derived agent.

R. Somerville, K. Fernie, H. Reichl, 2000, The Journal of hospital infection.

Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)‐treated plasma OctaplasLG®

J. Römisch, T. Svae, A. Neisser-Svae, 2009, Vox sanguinis.

Studies on the removal of a bovine spongiform encephalopathy‐derived agent by processes used in the manufacture of human immunoglobulin

R. Somerville, I. Macgregor, K. Fernie, 2002, Vox sanguinis.

Prion protein: detection in 'spiked' anaerobic sludge and degradation experiments under anaerobic conditions.

R. Somerville, R. Braun, R. Kirchmayr, 2006, Water science and technology : a journal of the International Association on Water Pollution Research.

Distribution of a bovine spongiform encephalopathy‐derived agent over ion‐exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII

R. Somerville, R. Mcintosh, B. Griffin, 2004, Vox sanguinis.